References
- Alvero AB (2010). Recent insights into the role of NF-kappaB in ovarian carcinogenesis. Genome Med, 2, 56. https://doi.org/10.1186/gm177
- Ashraf N, Zino S, Macintyre A, et al (2006). Altered sirtuin expression is associated with node-positive breast cancer. Br J Cancer, 95, 1056-61. https://doi.org/10.1038/sj.bjc.6603384
- Barber MF, Michishita-Kioi E, Xi Y, et al (2012). SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation. Nature, 487, 114-8.
- Blander G, Guarente L (2004). The Sir2 family of protein deacetylases. Annu Rev Biochem, 73, 417-35. https://doi.org/10.1146/annurev.biochem.73.011303.073651
- Bosch-Presegue L, Vaquero A (2011). The dual role of sirtuins in cancer. Genes Cancer, 2, 648-662. https://doi.org/10.1177/1947601911417862
- Chen WT, Gao X, Han XD, et al (2014). HE4 as a serum biomarker for ROMA prediction and prognosis of epithelial ovarian cancer. Asian Pac J Cancer Prev, 15, 101-5. https://doi.org/10.7314/APJCP.2014.15.1.101
- Ford E, Voit R, Liszt G, et al (2006). Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription. Genes Dev, 20, 1075-80. https://doi.org/10.1101/gad.1399706
- Han Y, Liu Y, Zhang H, et al (2013). Hsa-miR-125b suppresses bladder cancer development by down-regulating oncogene SIRT7 and oncogenic long noncoding RNA MALAT1. FEBS Lett, 587, 3875-82. https://doi.org/10.1016/j.febslet.2013.10.023
- Jemal A, Murray T, Samuels A, et al (2003). Cancer statistics, 2003. CA Cancer J Clin, 53, 5-26. https://doi.org/10.3322/canjclin.53.1.5
- Kim JK, Noh JH, Jung KH, et al (2013). Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b. Hepatology, 57, 1055-67. https://doi.org/10.1002/hep.26101
- Lai CC, Lin PM, Lin SF, et al (2013). Altered expression of SIRT gene family in head and neck squamous cell carcinoma. Tumour Biol, 34, 1847-54. https://doi.org/10.1007/s13277-013-0726-y
- Lavu S, Boss O, Elliott PJ, et al (2008). Sirtuins--novel therapeutic targets to treat age-associated diseases. Nat Rev Drug Discov, 7, 841-53. https://doi.org/10.1038/nrd2665
- North BJ, Verdin E (2004). Sirtuins: Sir2-related NADdependent protein deacetylases. Genome Biol, 5, 224. https://doi.org/10.1186/gb-2004-5-5-224
- Shin J, He M, Liu Y, et al (2013). SIRT7 represses Myc activity to suppress ER stress and prevent fatty liver disease. Cell Rep, 5, 654-65. https://doi.org/10.1016/j.celrep.2013.10.007
- Tsai YC, Greco TM, Boonmee A, et al (2012). Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription. Mol Cell Proteomics, 11, 60-76. https://doi.org/10.1074/mcp.A111.015156
- Vakhrusheva O, Smolka C, Gajawada P, et al (2008). Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice. Circ Res, 102, 703-10. https://doi.org/10.1161/CIRCRESAHA.107.164558
- Yu H, Ye W, Wu J, et al (2014). Overexpression of sirt7 exhibits oncogenic property and serves as a prognostic factor in colorectal cancer. Clin Cancer Res, 20, 3434-45. https://doi.org/10.1158/1078-0432.CCR-13-2952
Cited by
- MicroRNA-3666-induced suppression of SIRT7 inhibits the growth of non-small cell lung cancer cells vol.36, pp.5, 2016, https://doi.org/10.3892/or.2016.5063
- Sirtuins Expression and Their Role in Retinal Diseases vol.2017, pp.1942-0994, 2017, https://doi.org/10.1155/2017/3187594
- Multiomics Analysis of Tumor Microenvironment Reveals Gata2 and miRNA-124-3p as Potential Novel Biomarkers in Ovarian Cancer vol.21, pp.10, 2017, https://doi.org/10.1089/omi.2017.0115
- The seven faces of SIRT7 vol.8, pp.2, 2017, https://doi.org/10.1080/21541264.2016.1276658
- MicroRNA-3666 inhibits breast cancer cell proliferation by targeting sirtuin 7 vol.16, pp.6, 2017, https://doi.org/10.3892/mmr.2017.7603
- Genetic variants in the histone methylation and acetylation pathway and their risks in eight types of cancers vol.19, pp.2, 2018, https://doi.org/10.1111/1751-2980.12574
- Advances in Cellular Characterization of the Sirtuin Isoform, SIRT7 vol.9, pp.1664-2392, 2018, https://doi.org/10.3389/fendo.2018.00652
- Sirtuin 7 Deficiency Ameliorates Cisplatin-induced Acute Kidney Injury Through Regulation of the Inflammatory Response vol.8, pp.1, 2018, https://doi.org/10.1038/s41598-018-24257-7
- Dual Tumor Suppressor and Tumor Promoter Action of Sirtuins in Determining Malignant Phenotype vol.10, pp.1663-9812, 2019, https://doi.org/10.3389/fphar.2019.00038